Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Five-Gene and Corresponding Protein Signature for Stage-I Lung Adenocarcinoma Prognosis

16 Dec 2010

Abstract excerpt

PURPOSE: Identification of effective markers for outcome is expected to improve the clinical management of non-small cell lung cancer (NSCLC). Here, we assessed in NSCLC the prognostic efficacy of genes, which we had previously found to be differentially expressed in an in vitro model of human lung carcinogenesis. EXPERIMENTAL DESIGN: Prediction algorithms and risk-score models were applied to the expression of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bioinformatics and Genomic Networks
Share to Ferroptosis and cancer prognosis
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21163870
DOI: 10.1158/1078-0432.ccr-10-2703

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Five-Gene and Corresponding Protein Signature for Stage-I Lung Adenocarcinoma PrognosisPMID 21163870Read ↗

Identification of a Sixteen-gene Prognostic Biomarker for Lung Adenocarcinoma Using a Machine Learning MethodSemantic proximity Read ↗

Gene expression-based identification of prognostic markers in lung adenocarcinomaSemantic proximity Read ↗

Lung adenocarcinoma pathology stages related gene identificationSemantic proximity Read ↗

Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma.Semantic proximity Read ↗

An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers.Semantic proximity Read ↗

Combination of Protein Coding and Noncoding Gene Expression as a Robust Prognostic Classifier in Stage I Lung AdenocarcinomaSemantic proximity Read ↗

Non-Overlapping and Non–Cell-Type–Specific Gene Expression Signatures Predict Lung Cancer SurvivalSemantic proximity Read ↗

Development and Validation of a Prognostic Gene-Expression Signature for Lung AdenocarcinomaSemantic proximity Read ↗

A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung CancerSemantic proximity Read ↗

Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non–Small Cell Lung CancerSemantic proximity Read ↗

Early2 factor (E2F) deregulation is a prognostic and predictive biomarker in lung adenocarcinomaSemantic proximity Read ↗

Simplified Molecular Classification of Lung Adenocarcinomas Based on <i>EGFR</i> , <i>KRAS</i> , and <i>TP53</i> MutationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.